Next 10 |
home / stock / biovf / biovf news
2024-02-08 14:21:03 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2023 Results Conference Call February 08, 2024 08:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Lydia Abad-Franch - Head of R&a...
2024-02-08 06:11:24 ET More on Swedish Orphan Biovitrum AB Historical earnings data for Swedish Orphan Biovitrum AB Financial information for Swedish Orphan Biovitrum AB Read the full article on Seeking Alpha For further details see: Swedish Orphan Biovit...
2024-01-14 12:00:24 ET More on CRISPR, GSK, etc. Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry CRISPR Therapeutics AG (CRSP) 42nd Annual J.P. Morgan Healthcare Conference (Transcript) ...
2023-10-30 14:39:02 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2023 Earnings Conference Call October 30, 2023, 8:00 a.m. ET Company Participants Guido Oelkers - CEO Henrik Stenqvist - CFO Lydia Abad-Franch - Head of R&D and Chief Medical Officer Arm...
2023-10-30 12:17:25 ET More on Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB (publ) 2023 Q3 - Results - Earnings Call Presentation Apellis extends selloff as JPMorgan becomes latest to downgrade Historical earnings data for Swedish Orphan Biovitrum AB ...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023
2023-08-03 10:40:25 ET More on Apellis Pharmaceuticals Apellis: Exercise Caution In Response To Safety Signal (Rating Downgrade) Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space Apellis off 18% despite reassurance of safety of vision drug, earnin...
2023-07-18 16:45:19 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2023 Results Conference Call July 18, 2023 07:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Armin Reininger - Senior Scientific...
2023-07-18 08:24:42 ET Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q2 Non-GAAP EPS of SEK1.48. Revenue of SEK4.87B (+25.8% Y/Y) misses by $419.36M . For further details see: Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK1.48, revenue of SEK4.87M m...
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023
As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Ab...